Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine When Administered in Children Who Previously Participated in Study 115345
Clinical trial NCT01702454 · COMPLETED
Trial details
- NCT number
- NCT01702454
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-06
- Primary completion
- 2013-05-06
- Enrollment
- 470
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.